Bloomberg Markets with Carol Massar and Cory Johnson.
GUEST:
Tatiana Darie
Health Care Stocks Reporter
Bloomberg News
Discussing Vertex Pharmaceuticals Inc. surging on Wednesday as its experimental new drug combinations helped more cystic fibrosis patients breathe far better than doctors and investors expected, opening a path to improved treatment for almost all patients with the lung disorder.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com